|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Company details: Hospira, Inc.
Group companies: Hospira, Inc.
| Name | Category and Sector |
|---|---|
Hospira UK Ltd.
 Hospira UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products |
Pharmaceuticals: Major
|
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | -4.52% | +18.91% | +67.25% | 48.26B | |
| +0.34% | -5.00% | +38.85% | +117.44% | 40.5B | |
| +0.72% | -1.01% | -10.20% | +11.66% | 11.85B | |
| +3.29% | -0.38% | +14.11% | +82.76% | 11.83B | |
| -1.50% | -0.38% | +24.76% | +138.18% | 9.36B | |
| -0.86% | -3.20% | +23.76% | +38.38% | 7.5B | |
| +0.10% | -2.60% | +36.28% | -13.54% | 7.37B | |
| +0.60% | -1.13% | +19.49% | +208.86% | 7.28B | |
| -0.32% | -1.85% | -46.31% | +22.01% | 5.19B | |
| Average | +0.24% | -2.35% | +13.29% | +74.78% | 16.57B | |
| Weighted average by Cap. | +0.23% | -1.85% | +20.86% | +82.04% |
- Stock Market
- Stocks
- Stock
- Company Hospira, Inc.
Select your edition
All financial news and data tailored to specific country editions
